-
101
904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
Published 2021-11-01Article -
102
-
103
Let’s talk about race: changing the conversations around race in academia
Published 2021-08-01Get full text
Article -
104
Response to ‘Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers (pHCWs)’
Published 2021-05-01Get full text
Article -
105
-
106
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Published 2019-04-01Get full text
Article -
107
Association of systemic inflammation with posttraumatic stress disorder after a myocardial infarction
Published 2023-07-01Get full text
Article -
108
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
Published 2019-08-01“…Methods We conducted a retrospective review of 90 patients treated on IO-based phase 1 clinical trials at Winship Cancer Institute of Emory University between 2009 and 2017. Overall survival (OS) and progression-free survival (PFS) were measured from the first dose of IO to date of death or hospice referral and clinical or radiographic progression, respectively. …”
Get full text
Article -
109
-
110
-
111
-
112
Ten-eleven translocation protein 1 modulates medulloblastoma progression
Published 2021-04-01Get full text
Article -
113
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
Published 2022-03-01Get full text
Article -
114
Sex Differences in Mental Stress‐Induced Myocardial Ischemia in Patients With Coronary Heart Disease
Published 2016-09-01Get full text
Article -
115
-
116
The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy
Published 2023-04-01Get full text
Article -
117
-
118
Evolution of two distinct variable lymphocyte receptors in lampreys: VLRD and VLRE
Published 2023-08-01Get full text
Article -
119
AMPK activator-treated human cardiac spheres enhance maturation and enable pathological modeling
Published 2023-11-01Get full text
Article -
120